← Eichor
Condition: Dengue Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dengue

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean
Phase N/A · 1 location(s) · University Hospital Center of Martinique · NCT04839757Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Phase 3 · 5 location(s) · Butantan Institute · NCT06891950Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
Phase 3 · 41 location(s) · Merck Sharp & Dohme LLC · NCT07013487A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue
Phase N/A · 7 location(s) · Takeda · NCT06843226A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)
Phase 2/Phase 3 · 2 location(s) · Hyundai Bioscience Co., Ltd. · NCT07576868Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
Phase N/A · 1 location(s) · Jose Ivan Rodriguez de Molina Serrano · NCT07007585International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)
Phase N/A · 1 location(s) · Mahidol University · NCT07409857Dengvaxia US Pregnancy Registry
Phase N/A · 1 location(s) · Sanofi Pasteur, a Sanofi Company · NCT04486638Impact of IIT-SIT on Dengue Clusters
NA · 1 location(s) · National Environment Agency, Singapore · NCT06894901A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT06006559A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
Phase 3 · 7 location(s) · Takeda · NCT06579755A Controlled Human Infection Model of Dengue
NA · 1 location(s) · Tan Tock Seng Hospital · NCT07412483Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)
NA · 2 location(s) · Chulalongkorn University · NCT05631405Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients
Phase 2/Phase 3 · 1 location(s) · Phramongkutklao College of Medicine and Hospital · NCT06747130Adaptive Dengue Antiviral Platform Trial
Phase 2 · 2 location(s) · Oxford University Clinical Research Unit, Vietnam · NCT06551844Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus
Phase N/A · 1 location(s) · IRCCS Sacro Cuore Don Calabria di Negrar · NCT06776692Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07000747Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Hetero
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07706686Innovative Multidisciplinary Strategies for Combating Severe Dengue
Phase N/A · 2 location(s) · Karolinska Institutet · NCT06751836Immune Responses to Dengue and Sepsis
Phase N/A · 3 location(s) · Institut Pasteur du Cambodge · NCT07040202A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
Phase 3 · 4 location(s) · Takeda · NCT06665035Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05400824Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
Phase 2 · 2 location(s) · George Washington University · NCT04597437
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.